Lifang Zhang
机构:Wenzhou Medical University · ORCID:0000-0002-0548-1507
发表论文 150 篇 · 总被引 2706 次 · h-index 28
代表论文
- Evaluating the health risk of probiotic supplements from the perspective of antimicrobial resistance (2024 · Microbiology Spectrum · 被引 40)
- Peptide Supramolecular Hydrogels with Sustained Release Ability for Combating Multidrug-Resistant Bacteria (2023 · ACS Applied Materials & Interfaces · 被引 20)
- PDGFR-β/Cav1-induced autophagy via mTOR/FIP200/ATG13 activation in cancer-associated fibroblasts promotes the malignant progression of breast cancer (2025 · Journal of Translational Medicine · 被引 7)
- Selenium Broussonetia papyrifera polysaccharide alleviated cyclophosphamide-induced immune suppression, growth inhibition, intestinal damage, and gut microbiota disorder in yellow-feather broilers. (2025 · Poultry Science · 被引 5)
- Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma (2023 · International Journal of Molecular Sciences · 被引 5)
- Recent status and trends of innate immunity and the gut-kidney aixs in IgAN: A systematic review and bibliometric analysis (2024 · International Immunopharmacology · 被引 4)